Latest news
China accepts NDA for Alebund's phosphate binder AP301 after Phase III success - AllSciAllSci · Fri, 07 Aug 2026 16:31:47 GMTBioInvent wins FDA Fast Track for BI-1808 after encouraging ovarian cancer data - AllSciAllSci · Fri, 07 Aug 2026 16:28:01 GMTSino Bio's benmelstobart-anlotinib regimen adds new China indication in first-line squamous NSCLC - AllSciAllSci · Fri, 07 Aug 2026 16:21:02 GMTEU clears label expansion for Bavarian Nordic's Mpox vaccine to children as young as two - AllSciAllSci · Fri, 07 Aug 2026 13:40:45 GMTReplimune secures accelerated approval for oncolytic viral therapy Tudriqev - AllSciAllSci · Fri, 07 Aug 2026 13:34:42 GMTTransThera Wins First China Approval for Yochanra in Advanced Cholangiocarcinoma - TipRanksTipRanks · Fri, 07 Aug 2026 05:38:49 GMTTransThera wins first China approval in post-FGFR cholangiocarcinoma - AllSciAllSci · Thu, 06 Aug 2026 16:41:13 GMTTakeda ushers in the orexin era with landmark FDA approval - AllSciAllSci · Thu, 06 Aug 2026 09:28:45 GMT